Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.08 - $2.35 $14,040 - $30,550
13,000 New
13,000 $16,000
Q2 2022

Jul 21, 2022

SELL
$2.81 - $12.91 $87,953 - $404,083
-31,300 Reduced 18.14%
141,200 $494,000
Q1 2022

Apr 20, 2022

BUY
$3.81 - $9.79 $657,225 - $1.69 Million
172,500 New
172,500 $2.03 Million

Others Institutions Holding CELU

About Celularity Inc


  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $319M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.